HEOR in the Era of Generative AI: Navigating the New Frontiers
Author(s)
Rachael Fleurence, PhD, National Institutes of Health, Bethesda, MD, USA, Xiaoyan Wang, PhD, IMO health, Rosemont, IL, USA, Dalia Dawoud, PhD, National Institute of Health and Care Excellence, London, UK and Jag Chhatwal, PhD, Mass General Hospital, Harvard Medical School and Value Analytics Labs, Wilmington, MA, USA
OVERVIEW: The session, moderated by Jag Chhatwal, will begin with an exploration of the current generative AI landscape and its intersections with HEOR. Rachael Fleurence will illustrate practical applications, as well as limitations, of generative AI in systematic literature reviews, evidence synthesis and real-world evidence. Xiaoyan Wang will discuss the potential of generative AI in developing synthetic or external control arms, which could significantly expedite the evidence generation process for clinical trials. Jag Chhatwal will present the current uses of generative AI in health economic modeling, highlighting both the current capabilities and challenges. Finally, Dalia Dawoud will discuss how HTA may adapt evaluation methods and processes in response to submissions that employ generative AI.
The session will feature interactive polling to engage attendees actively and gather their insights. By bringing together diverse expert views, this session aims to foster a comprehensive understanding of the multifaceted roles, ongoing challenges, and future prospects of generative AI in HEOR. It will also address the existing uncertainties and skepticism surrounding the adoption of generative AI in HEOR.
Conference/Value in Health Info
Topic
Health Technology Assessment